Search

Search Results

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• Gene Methylation Profile in Hematologic Malignancies

  Mariia Andreevna Mikhaleva, A.A. Zherniakova, O.B. Krysiuk, S.V. Sidorkevich

  27-38

  01.01.2026

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Treatment of Patients with Relapsed/Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Own Data and Literature Review

  Arman Vachakanovich Arakelyan, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, I.S. Monin, N.M. Zolotaikina, G.D. Petrova, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, V.Yu. Kirsanov

  38-50

  01.01.2025

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Treatment of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

  Aleksander Sergeevich Luchinin

  130-139

  01.04.2022

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male Siblings

  Nadezhda Viktorovna Kurkina, E.A. Repina

  69-72

  01.01.2021

• Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

  Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya

  25-32

  01.01.2020

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019

• The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients

  Nadezhda Viktorovna Kurkina, E.A. Repina, N.N. Mashnina

  278-281

  01.07.2019

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

  Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich

  381-389

  01.07.2017

• Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

  N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa

  13-21

  01.01.2016

• Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  379-389

  01.10.2015

• High-risk chronic lymphocytic leukemia: history, definition, diagnosis, and management

  E.A. Nikitin, A.B. Sudarikov

  60-68

  01.01.2013